| Trial ID: | L5549 |
| Source ID: | NCT00393770
|
| Associated Drug: |
L-Acetylcarnitine
|
| Title: |
Acetylcarnitine and Insulin Sensitivity
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: L-acetylcarnitine
|
| Outcome Measures: |
Primary: Insulin sensitivity, At 0,3, 6 and 8 months. | Secondary: Lipid profile., At 0,3, 6 and 8 months.
|
| Sponsor/Collaborators: |
Sponsor: Mario Negri Institute for Pharmacological Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
43
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-02
|
| Completion Date: |
2007-09
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-10
|
| Locations: |
Clinical Research Center for Rare Diseases, Ranica, Bergamo, 24020, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT00393770
|
